CAPR - CAPRICOR THERAPEUTICS, INC.
33.98
-1.120 -3.296%
Share volume: 756,713
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$35.10
-1.12
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-08-2024 | 11-14-2024 | 03-26-2025 | 05-14-2025 | 08-11-2025 | 11-10-2025 | 03-17-2026 | |
| Assets | |||||||||
| Total Assets | 49.444 M | 38.277 M | 92.952 M | 170.481 M | 153.766 M | 133.569 M | 126.438 M | 355.949 M | |
| Current Assets | 41.412 M | 30.669 M | 85.823 M | 163.385 M | 146.251 M | 124.127 M | 100.952 M | 322.940 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 369.000 K | 369.975 K | 409.682 K | 10.368 M | 59.834 K | 59.509 K | 59.167 K | 59.167 K | |
| Short Term Investments | 33.702 M | 18.774 M | 16.651 M | 140.229 M | 115.983 M | 99.559 M | 79.056 M | 30.282 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 6.215 M | 10.688 M | 68.377 M | 11.287 M | 28.795 M | 23.241 M | 19.510 M | 287.847 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 5.894 M | 5.618 M | 5.315 M | 5.562 M | 6.134 M | 7.995 M | 11.068 M | 18.312 M | |
| Other Assets | 1.845 M | 1.991 M | 1.813 M | 1.534 M | 1.381 M | 1.447 M | 14.418 M | 14.697 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 49.444 M | 38.277 M | 92.952 M | 170.481 M | 153.766 M | 133.569 M | 126.438 M | 355.949 M | |
| Total liabilities | 31.010 M | 26.775 M | 24.687 M | 25.019 M | 26.121 M | 28.592 M | 42.571 M | 50.157 M | |
| Total current liabilities | 26.384 M | 22.355 M | 20.476 M | 21.026 M | 22.337 M | 28.397 M | 28.148 M | 35.837 M | |
| Accounts Payable | 6.249 M | 6.170 M | 6.531 M | 8.191 M | 5.254 M | 4.812 M | 2.719 M | 1.655 M | |
| Other liabilities | 1.249 M | 1.044 M | 834.889 K | 3.993 M | 3.784 M | 194.603 K | 14.423 M | 14.320 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 3.376 M | 3.376 M | 3.376 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.249 M | 1.044 M | 834.889 K | 3.993 M | 3.784 M | 194.603 K | 14.423 M | 14.320 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 18.435 M | 11.502 M | 68.265 M | 145.462 M | 127.645 M | 104.977 M | 83.867 M | 305.792 M | |
| Common stock | 187.289 M | 191.509 M | 260.887 M | 344.270 M | 350.060 M | 353.726 M | 357.731 M | 610.387 M | |
| Retained earnings | -169.161 M | -180.161 M | -192.718 M | -199.835 M | -224.226 M | -250.137 M | -274.708 M | -304.878 M |